DC

Dinesh Chand

Director Director DIN 09546001
DIN 09546001 First appointment Mar 2022 Primary industry Trading
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Mar 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Dinesh Chand

Data last updated:

Dinesh Chand was a Director at Sivera Wellness Private Limited (2022–2023) and Director at Baylen Pharmaceuticals Private Limited (from 2022). The companies operate in Trading.

DIN 09546001
Primary Designation Director
Industry Trading
First Appointment 24 Mar 2022
Oldest Company Age 4 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Sivera Wellness Private Limited U51909UP2022PTC169011
Director12 Aug 20222022₹3.4 Lakh (FY 2024)Active
Director24 Mar 20222022Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Baylen Pharmaceuticals Private Limited
Sivera Wellness Private Limited
Premium access

Shareholding and investment profile for Dinesh Chand

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Dinesh Chand

Dinesh Chand was first appointed on 24 Mar 2022 as Director at Baylen Pharmaceuticals Private Limited.

Dinesh Chand held 2 earlier board appointments: Sivera Wellness Private Limited (Director, 12 Aug 2022 to 19 Oct 2023); Baylen Pharmaceuticals Private Limited (Director, from 24 Mar 2022).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available